Device Trial Radar · NCT07485075
Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
Last checked: Nov 20, 2026Latest source record: Mar 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
104
Planned (sponsor's estimate)
Start
Mar 20, 2026
Primary completion
Dec 31, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Steno Diabetes Center CopenhagenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 20, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).
Conditions
- Diabetes Type 2
- Kidney Disease
Interventions
StenoFood AppDevice
Digital patient education program (app-based) with dietary guidance and self-monitoring tools
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in sodium excretion between measurements at baseline and 6 months follow-upTime frame: 6 month
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Steno Diabetes Center Copenhagen,
Herlev, Captial Region of Denmark, Denmark · Recruiting
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.